Literature DB >> 7489926

The management of chronic hepatitis C virus infection.

J C Booth1, J L Brown, H C Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7489926      PMCID： PMC1382891          DOI： 10.1136/gut.37.4.449

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  93 in total

1.  One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b.

Authors:  P Ferenci; W Vogel; H Pristautz; J Deimer; H Denk; G Judmaier; K P Maier; G J Krejs; A Gangl
Journal:  J Hepatol       Date:  1990       Impact factor: 25.083

2.  Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group.

Authors:  M Gómez-Rubio; J C Porres; I Castillo; J A Quiroga; A Moreno; V Carreño
Journal:  J Hepatol       Date:  1990       Impact factor: 25.083

3.  Hepatitis C virus not found in fulminant non-A, non-B hepatitis.

Authors:  T L Wright; H Hsu; E Donegan; S Feinstone; H Greenberg; A Read; N L Ascher; J P Roberts; J R Lake
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

4.  Transmission of hepatitis C virus by organ transplantation.

Authors:  B J Pereira; E L Milford; R L Kirkman; A S Levey
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

5.  Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction.

Authors:  M Giovannini; A Tagger; M L Ribero; G Zuccotti; L Pogliani; A Grossi; P Ferroni; A Fiocchi
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

6.  Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

Authors:  U Hopf; B Möller; D Küther; R Stemerowicz; H Lobeck; A Lüdtke-Handjery; E Walter; H E Blum; M Roggendorf; F Deinhardt
Journal:  J Hepatol       Date:  1990-01       Impact factor: 25.083

7.  A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; Z Goodman; S M Banks; J H Hoofnagle
Journal:  J Hepatol       Date:  1990       Impact factor: 25.083

8.  Ribavirin treatment for chronic hepatitis C.

Authors:  O Reichard; J Andersson; R Schvarcz; O Weiland
Journal:  Lancet       Date:  1991-05-04       Impact factor: 79.321

9.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

10.  Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

Authors:  X Causse; H Godinot; M Chevallier; P Chossegros; F Zoulim; D Ouzan; J P Heyraud; T Fontanges; J Albrecht; C Meschievitz
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682
View more
  6 in total

1.  Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection.

Authors:  Vincent Lo Re; Kevin Haynes; Kimberly A Forde; A Russell Localio; Rita Schinnar; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-09       Impact factor: 2.890

2.  Screening asymptomatic people at high risk for hepatitis C. The case against.

Authors:  M C Allison; P R Mills
Journal:  BMJ       Date:  1996-05-25

Review 3.  Pathophysiology and treatment of hepatitis C.

Authors:  H C Thomas; J Booth; J Brown
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease.

Authors:  C M da Silva; F L David; M N Muscará; S S Sousa; J G Ferraz; G de Nucci; N C Polimeno; J Pedrazzoli
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

5.  Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection.

Authors:  G H Haydon; L M Jarvis; C S Blair; P Simmonds; D J Harrison; K J Simpson; P C Hayes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

6.  Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study.

Authors:  M Wright; R Goldin; A Fabre; J Lloyd; H Thomas; C Trepo; P Pradat; M Thursz
Journal:  Gut       Date:  2003-04       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.